Medartis Holding AG
SIX:MED
Medartis Holding AG
Research & Development
Medartis Holding AG
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medartis Holding AG
SIX:MED
|
Research & Development
-CHf34.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Alcon AG
SIX:ALC
|
Research & Development
-$988m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Coltene Holding AG
SIX:CLTN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ypsomed Holding AG
SIX:YPSN
|
Research & Development
-CHf52.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
IVF Hartmann Holding AG
SIX:VBSN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medartis Holding AG
Glance View
Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
See Also
What is Medartis Holding AG's Research & Development?
Research & Development
-34.5m
CHF
Based on the financial report for Jun 30, 2025, Medartis Holding AG's Research & Development amounts to -34.5m CHF.
What is Medartis Holding AG's Research & Development growth rate?
Research & Development CAGR 5Y
-18%
Over the last year, the Research & Development growth was 0%. The average annual Research & Development growth rates for Medartis Holding AG have been -17% over the past three years , -18% over the past five years .
